問題一覧
1
Non opioid
2
Opioid
3
Non-steroidal Anti-inflammatory Drugs
4
Cyclooxygenase enzymes
5
Non-steroidal Anti-inflammatory Drugs
6
Non-steroidal Anti-inflammatory Drugs
7
Nabumetone
8
Fenoprofen & Piroxicam
9
Albumin
10
Salicylic acid derivatives
11
Para-chlorobenzoic acid derivatives or indoles
12
Pyrazolone derivatives
13
Arylpropionic acid
14
Fenamates/Anthranilic acids
15
Enolic acids/Oxicams
16
Heteroaryl/Phenylacetic acids
17
Alkalones
18
Aspirin
19
Pharmacokinetics aspirin
20
Pharmacodynamics aspirin
21
Gastric upset, Increases uric acid levels, Glucose intolerance , Salicylism
22
Warfarin, Spirinolactone, Penicillin, ACE inhibitors
23
Hemophilia, Gastric & duodenal ulcers
24
Diflunisal
25
Selective COX-2 Inhibitors
26
Paracetamol unwanted effects
27
Paracetamol
28
Corticosteroid drugs
29
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
30
Colchicine
31
Probenecid & Sulfinpyrazone
32
ALLOPURINOL
33
Febuxostat
34
Febuxostat pharmacodynamics
35
Pegloticase
36
Adverse effects Pegloticase
37
Mixed agonist antagonist
38
Antagonist
39
Agonist
40
Opioid antagonist
41
Opioid antagonist
42
Opioid antagonist
43
Pure agonists
44
Pure agonists
45
Pure agonists
46
Partial/Weak agonist
47
Partial/Weak agonist
48
Kappa
49
Dynorphins
50
K1
51
K3
52
Delta
53
U1
54
U2
55
Mu
56
Opioid Analgesics & Antagonists
57
Opioid Analgesics & Antagonists
58
Opioid Analgesics & Antagonists
59
Opioid Analgesics & Antagonists
60
Opioid Analgesics & Antagonists
61
Interleukin-1 Inhibitors
62
Interleukin-1 Inhibitors
63
Canakinumab
64
Non-selective COX inhibitors, Selective COX-2 inhibitors, Selective COX-3 inhibitor
65
Pure Agonists, Partial/Weak agonist, Mixed agonist-antagonists, Opioid antagonist
66
Methotrexate
67
Etanercept
68
Infliximab
69
Rituximab
70
Abatacept
71
Parecoxib
Sporeformers
Sporeformers
Tameyra Stefani Al-Suhairy · 44問 · 1年前Sporeformers
Sporeformers
44問 • 1年前Spirochetes
Spirochetes
Tameyra Stefani Al-Suhairy · 46問 · 1年前Spirochetes
Spirochetes
46問 • 1年前Subcutaneous, Systemic, Opportunistic Mycoses
Subcutaneous, Systemic, Opportunistic Mycoses
Tameyra Stefani Al-Suhairy · 75問 · 1年前Subcutaneous, Systemic, Opportunistic Mycoses
Subcutaneous, Systemic, Opportunistic Mycoses
75問 • 1年前Mycobacteria
Mycobacteria
Tameyra Stefani Al-Suhairy · 46問 · 1年前Mycobacteria
Mycobacteria
46問 • 1年前Bacterial Classification, morphology, utrastructure
Bacterial Classification, morphology, utrastructure
Tameyra Stefani Al-Suhairy · 64問 · 1年前Bacterial Classification, morphology, utrastructure
Bacterial Classification, morphology, utrastructure
64問 • 1年前HIV
HIV
Tameyra Stefani Al-Suhairy · 31問 · 1年前HIV
HIV
31問 • 1年前CORONA
CORONA
Tameyra Stefani Al-Suhairy · 24問 · 1年前CORONA
CORONA
24問 • 1年前PAPILLO
PAPILLO
Tameyra Stefani Al-Suhairy · 15問 · 1年前PAPILLO
PAPILLO
15問 • 1年前ADENO
ADENO
Tameyra Stefani Al-Suhairy · 16問 · 1年前ADENO
ADENO
16問 • 1年前POX
POX
Tameyra Stefani Al-Suhairy · 6問 · 1年前POX
POX
6問 • 1年前PARVO
PARVO
Tameyra Stefani Al-Suhairy · 25問 · 1年前PARVO
PARVO
25問 • 1年前HEPATOTROPHIC
HEPATOTROPHIC
Tameyra Stefani Al-Suhairy · 24問 · 1年前HEPATOTROPHIC
HEPATOTROPHIC
24問 • 1年前PICORNA
PICORNA
Tameyra Stefani Al-Suhairy · 25問 · 1年前PICORNA
PICORNA
25問 • 1年前RABIES
RABIES
Tameyra Stefani Al-Suhairy · 26問 · 1年前RABIES
RABIES
26問 • 1年前PARAMYXO
PARAMYXO
Tameyra Stefani Al-Suhairy · 20問 · 1年前PARAMYXO
PARAMYXO
20問 • 1年前HERPES
HERPES
Tameyra Stefani Al-Suhairy · 40問 · 1年前HERPES
HERPES
40問 • 1年前ORTHO
ORTHO
Tameyra Stefani Al-Suhairy · 7問 · 1年前ORTHO
ORTHO
7問 • 1年前FLAVI
FLAVI
Tameyra Stefani Al-Suhairy · 24問 · 1年前FLAVI
FLAVI
24問 • 1年前TOGA
TOGA
Tameyra Stefani Al-Suhairy · 19問 · 1年前TOGA
TOGA
19問 • 1年前VIRUS STRUCTURE
VIRUS STRUCTURE
Tameyra Stefani Al-Suhairy · 16問 · 1年前VIRUS STRUCTURE
VIRUS STRUCTURE
16問 • 1年前問題一覧
1
Non opioid
2
Opioid
3
Non-steroidal Anti-inflammatory Drugs
4
Cyclooxygenase enzymes
5
Non-steroidal Anti-inflammatory Drugs
6
Non-steroidal Anti-inflammatory Drugs
7
Nabumetone
8
Fenoprofen & Piroxicam
9
Albumin
10
Salicylic acid derivatives
11
Para-chlorobenzoic acid derivatives or indoles
12
Pyrazolone derivatives
13
Arylpropionic acid
14
Fenamates/Anthranilic acids
15
Enolic acids/Oxicams
16
Heteroaryl/Phenylacetic acids
17
Alkalones
18
Aspirin
19
Pharmacokinetics aspirin
20
Pharmacodynamics aspirin
21
Gastric upset, Increases uric acid levels, Glucose intolerance , Salicylism
22
Warfarin, Spirinolactone, Penicillin, ACE inhibitors
23
Hemophilia, Gastric & duodenal ulcers
24
Diflunisal
25
Selective COX-2 Inhibitors
26
Paracetamol unwanted effects
27
Paracetamol
28
Corticosteroid drugs
29
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
30
Colchicine
31
Probenecid & Sulfinpyrazone
32
ALLOPURINOL
33
Febuxostat
34
Febuxostat pharmacodynamics
35
Pegloticase
36
Adverse effects Pegloticase
37
Mixed agonist antagonist
38
Antagonist
39
Agonist
40
Opioid antagonist
41
Opioid antagonist
42
Opioid antagonist
43
Pure agonists
44
Pure agonists
45
Pure agonists
46
Partial/Weak agonist
47
Partial/Weak agonist
48
Kappa
49
Dynorphins
50
K1
51
K3
52
Delta
53
U1
54
U2
55
Mu
56
Opioid Analgesics & Antagonists
57
Opioid Analgesics & Antagonists
58
Opioid Analgesics & Antagonists
59
Opioid Analgesics & Antagonists
60
Opioid Analgesics & Antagonists
61
Interleukin-1 Inhibitors
62
Interleukin-1 Inhibitors
63
Canakinumab
64
Non-selective COX inhibitors, Selective COX-2 inhibitors, Selective COX-3 inhibitor
65
Pure Agonists, Partial/Weak agonist, Mixed agonist-antagonists, Opioid antagonist
66
Methotrexate
67
Etanercept
68
Infliximab
69
Rituximab
70
Abatacept
71
Parecoxib